NovaBay Pharmaceuticals (NBY) Q2 2024 Earnings

9MayConfirmed
Q1 2023
Q2 2023
Q3 2023
Q2 2024
-5.25
-3.62
-2
-0.37

Details

Expected EPS
-5.25
Actual EPS
-5.25
Surprise EPS
0
Surprise Percent
+0%

Description

NovaBay Pharmaceuticals (NBY) has reported earnings of -5.25 per share for Q2 2024.

0 Comments

Share your thoughts